<DOC>
	<DOCNO>NCT00449345</DOCNO>
	<brief_summary>The ministry health Israel require health-care worker undergo screen latent Tuberculosis infection ( LTBI ) prior start work . This base Mantoux skin test , notoriously unreliable . In recent year , specific sensitive test base interferon-gamma secretion TB antigens come market , current evidence show many mantoux positive person LTBI . Quantiferon-GOLD one assay . In prospective study , draw blood Quantiferon-GOLD assay parallel conventional testing , perform cost-effectiveness analysis cost investigation treatment LTBI health-care worker . We hypothesize spite cost screen healthcare worker Quantiferon-GOLD test , reduction need LTBI treatment associate cost render test cost-effective .</brief_summary>
	<brief_title>Screening Latent Tuberculosis Healthcare Workers With Quantiferon-Gold Assay : A Cost-Effectiveness Analysis</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<criteria>Health care worker undergo screen LTBI Previous tuberculosis treatment LTBI Immunosuppressed due drug treatment , HIV , organ transplant Recent TB contact</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>Latent tuberculosis infection</keyword>
	<keyword>Health care worker</keyword>
	<keyword>Tuberculin skin test</keyword>
	<keyword>Mantoux skin test</keyword>
	<keyword>Interferon gamma</keyword>
	<keyword>Quantiferon</keyword>
	<keyword>Cost effectiveness</keyword>
</DOC>